Skip to main content
. 2022 Sep 22;12(9):e064545. doi: 10.1136/bmjopen-2022-064545

Table 4.

Newly commissioned services and community pharmacy initiatives during the COVID-19 pandemic.

New services or initiatives Implemented in
March–May 2020
n (%)
Stopped in
June–August 2020
n (%)
Started at a later date
n (%)
Yes No Yes No
Emergency supply during a pandemic service 121 (93.1) 9 (6.9) * 117 (90.0) 0 (0.0)
Influenza vaccination service (front-line health and social care workers) 101 (77.7) 29 (22.3) 101 (77.7) 0 (0.0) 0 (0.0)
Situation reporting (staffing/stock) to the health and social care board 74 (56.9) 56 (43.1) 10 (7.7) 64 (49.2) 0 (0.0)
Measures to flag/assist patients with sensitive issues such as domestic violence reporting 73 (56.2) 57 (43.8) 0 (0.0) 73 (56.2) 6 (4.6)
Prescription delivery by volunteers in the local community 71 (54.6) 59 (45.4) 32 (24.6) 39 (30.0) 0 (0.0)
Referrals to test and trace services 70 (53.8) 60 (46.2) * 68 (52.3) 0 (0.0)
Employment of additional staff, for example, dentists, volunteers, students, retired pharmacists 49 (37.7) 81 (62.3) 22 (16.9) 27 (20.8) 0 (0.0)
Drive-through (or equivalent) pharmacy services 33 (25.4) 97 (74.6) * 32 (24.6) 0 (0.0)
Replenishment of care home pandemic packs 19 (14.6) 107 (82.4) * 15 (11.5) *
Palliative care on-call services 19 (14.6) 111 (85.4) * 17 (13.1) 0 (0.0)
Supply of medicines usually supplied in the hospital setting (eg, oncology, antiretroviral drugs, ‘Healthcare at Home’) 11 (8.5) 119 (91.5) 0 (0.0) 11 (8.5) 0 (0.0)
Medicines delivery service (to vulnerable people) (commissioned September 2020) n/a n/a n/a n/a 95 (73.1)

*Not reported as less than 5, and potentially identifiable.